HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Homeopathic Firm Rebrands As Hyland’s Naturals With Shift To Focus On Supplement Market

Executive Summary

Hyland’s Naturals focused for nearly 120 years on providing consumer health products in the pediatric and general wellness categories and is expanding into the women’s health and pet categories. Also will launch more than 20 natural wellness products over the next year.

You may also be interested in...



HBW Market News: Hyland’s Launches Walmart Exclusive; Healright Bars In Kroger Stores; More

Herbalife extends LA Galaxy partnership; Looni offers menstrual health supplement; Hyland’s Natural launches Baby and Kids cough, immune Products; and Healright Daily Micronutrient Bars In Krogers’ Little Clinics.

Homeopathic Market Doesn't 'Disappear' – FDA Forced To Act

"This was an area that the agency thought was just going to disappear on its own," says Freddie Ann Hoffman, who chaired FDA homeopathic working group that helped develop CPG adopted in 1988 to allow sales of homeopathics to continue without pre-market approval.

FDA Adds Homeopathic Enforcement Details, Subtracts Compliance Policy Guide

Revised draft guidance identifies types of homeopathics posing "higher risks to public health." FDA withdraws 1988 compliance policy guide that allows homeopathic to be available even though they are not subject to pre-market approval or other review process agency imposes on all other drugs.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152522

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel